A detailed history of Geneos Wealth Management Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 9,885 shares of CRL stock, worth $1.91 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
9,885
Previous 9,023 9.55%
Holding current value
$1.91 Million
Previous $1.86 Million 4.51%
% of portfolio
0.07%
Previous 0.08%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$187.96 - $245.29 $162,021 - $211,439
862 Added 9.55%
9,885 $1.95 Million
Q2 2024

Jul 23, 2024

BUY
$206.39 - $268.73 $287,707 - $374,609
1,394 Added 18.27%
9,023 $1.86 Million
Q1 2024

May 03, 2024

BUY
$203.52 - $273.43 $532,611 - $715,566
2,617 Added 52.21%
7,629 $2.07 Million
Q4 2023

Jan 26, 2024

SELL
$164.52 - $238.84 $1,974 - $2,866
-12 Reduced 0.24%
5,012 $1.18 Million
Q3 2023

Oct 11, 2023

BUY
$194.44 - $217.61 $38,693 - $43,304
199 Added 4.12%
5,024 $984,000
Q2 2023

Aug 08, 2023

BUY
$183.71 - $210.25 $97,366 - $111,432
530 Added 12.34%
4,825 $1.01 Million
Q1 2023

Apr 25, 2023

BUY
$191.89 - $259.92 $812,846 - $1.1 Million
4,236 Added 7179.66%
4,295 $866,000
Q4 2021

Feb 09, 2022

BUY
$351.38 - $448.68 $19,325 - $24,677
55 Added 1375.0%
59 $22,000
Q2 2021

Jul 08, 2021

SELL
$294.17 - $371.65 $204,448 - $258,296
-695 Reduced 99.43%
4 $1,000
Q1 2021

Jun 17, 2021

BUY
$249.67 - $299.48 $16,228 - $19,466
65 Added 10.25%
699 $232,000
Q4 2020

May 19, 2021

BUY
$222.0 - $252.62 $140,748 - $160,161
634 New
634 $1,000
Q4 2019

Sep 07, 2021

SELL
$126.05 - $152.76 $1,008 - $1,222
-8 Closed
0 $0
Q3 2019

Sep 07, 2021

BUY
$125.07 - $143.67 $1,000 - $1,149
8 New
8 $1,000
Q2 2017

Sep 07, 2021

SELL
N/A
-18 Closed
0 $0
Q1 2017

Sep 07, 2021

SELL
N/A
-9 Reduced 33.33%
18 $1,000
Q3 2016

Sep 07, 2021

BUY
N/A
27
27 $2,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.84B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Geneos Wealth Management Inc. Portfolio

Follow Geneos Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.